跳至主要内容
临床试验/ACTRN12621000188831
ACTRN12621000188831招募中未知

Implementation and evaluation of a nurse-enabled, shared-care follow-up model for early breast cancer survivors on health-related quality of life (The IBIS-Survivorship Study)

Professor Raymond Chan0 个研究点目标入组 1,358 人开始时间: 2021年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,358

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Early breast cancer as defined as stage I-III (inclusive of ductal carcinoma in situ (DCIS) and locally advanced breast cancer but no distant metastases) who are:
  • - within ten weeks of completion of adjuvant treatment for early stage breast cancer at a participating site; OR within ten weeks post-surgery if not scheduled for further adjuvant therapy;
  • - Can identify a regular GP;
  • - Ambulatory with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2; and
  • - Able to read and understand English.
  • Recurrent or secondary primary breast cancer, comorbidities, other prior cancer diagnoses or Trastuzumab (or biosimilars), neoadjuvant and/or ongoing endocrine therapies are NOT exclusion criteria

排除标准

  • - have metastatic (distant) breast cancer; or
  • - the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate at the discretion of treating clinicians

研究者

发起方
Professor Raymond Chan

相似试验